Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia Reply

被引：0
|
作者：
You, Benoit [1 ,2 ,3 ]
Bolze, Pierre-Adrien [1 ,2 ,4 ]
Golfier, Francois [1 ,2 ,4 ]
机构：
[1] Ctr Reference Malad Trophoblast, Lyon, France
[2] Univ Claude Bernard Lyon 1, Univ Lyon, EMR UCBL, HCL 3738, Lyon, France
[3] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Inst Cancerol, Med Oncol,IC HCL,CITOHL, Lyon, France
[4] Hosp Civils Lyon, Serv Chirurg Gynecol & Oncol, Obstet, Ctr Hosp Lyon Sud, Pierre Benite, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 36期
关键词：
PEMBROLIZUMAB; PHASE-3;
D O I：
10.1200/JCO.20.02911
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4350 / +
页数：3
相关论文
共 50 条
  • [31] Low-risk gestational trophoblastic neoplasia - Evaluating the need for initial inpatient treatment during low-dose methotrexate chemotherapy
    Carter, Lucy D.
    Hancock, Barry W.
    Everard, Janet E.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2008, 53 (07) : 525 - 527
  • [32] Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia
    Braga, Antonio
    Elias, Kevin M.
    Horowitz, Neil S.
    Berkowitz, Ross S.
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2021, 43 (07): : 503 - 506
  • [33] Methotrexate infusion in low-risk gestational trophoblastic disease
    Wong, LC
    Ngan, HYS
    Cheng, DKL
    Ng, TY
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (06) : 1579 - 1582
  • [34] The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy
    Wu, Xiaodong
    Qin, Jiale
    Shen, Tao
    Fei, Weidong
    Chen, Lili
    Xie, Xing
    Lu, Weiguo
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (04) : 1 - 11
  • [35] Low-Risk Gestational Trophoblastic Neoplasia and Methotrexate Resistance Predictors of Response to Treatment with Actinomycin D and Need for Combination Chemotherapy
    Growdon, Whitfield B.
    Wolfberg, Adam J.
    Goldstein, Donald P.
    Feltmate, Colleen M.
    Chinchilla, Manuel E.
    Lieberman, Ellice S.
    Berkowitz, Ross S.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2010, 55 (7-8) : 279 - 284
  • [36] Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia
    Strohl, Anna E.
    Lurain, John R.
    GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 276 - 280
  • [37] Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia
    Lybol, C.
    Sweep, F. C. G. J.
    Harvey, R.
    Mitchell, H.
    Short, D.
    Thomas, C. M. G.
    Ottevanger, P. B.
    Savage, P. M.
    Massuger, L. F. A. G.
    Seckl, M. J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 576 - 579
  • [38] Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocol
    Branco-Silva, Mariza
    Maesta, Izildinha
    Elias, Kevin
    Berkowitz, Ross Stuart
    Abbade, Joelcio Francisco
    Horowitz, Neil S.
    BMJ OPEN, 2022, 12 (02):
  • [39] A Cost Analysis of First-Line Chemotherapy for Low-Risk Gestational Trophoblastic Neoplasia
    Shah, Neel T.
    Barroilhet, Lisa
    Berkowitz, Ross S.
    Goldstein, Donald P.
    Horowitz, Neil
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (5-6) : 211 - 218
  • [40] SINGLE-DOSE METHOTREXATE IN THE TREATMENT OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA - AN UPDATED RESULTS
    Ngu, S. F.
    Tse, K. Y.
    Chu, M. Y. M.
    Sheung, P. N. H.
    Chan, K. L. K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A140 - A140
12345